Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2016
[Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck]
A Modesto, J Sarini, A Benlyazid, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 8, 2023
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers
F Huguet, O Riou, D Pasquier, et al.
Oral and Maxillofacial Surgery
|
September 29, 2020
COMT rs4818, pain sensitivity and duration, and alveolar bone grafting of oral clefts
E M V M Silva, R H W Lacerda, I L Farias, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
December 26, 2021
Rectal cancer radiotherapy
V Vendrely, E Rivin Del Campo, A Modesto, et al.
Oral Oncology
|
June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
A Modesto, P Blanchard, Y G Tao, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
April 4, 2013
Candidate gene studies in hypodontia suggest role for FGF3
A R Vieira, R N D'Souza, G Mues, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 10, 2024
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers]
F Guillemin, P Blanchard, P Boisselier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Y Tao, J Biau, X S Sun, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2016
[Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck]
A Modesto, J Sarini, A Benlyazid, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 8, 2023
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers
F Huguet, O Riou, D Pasquier, et al.
Oral and Maxillofacial Surgery
|
September 29, 2020
COMT rs4818, pain sensitivity and duration, and alveolar bone grafting of oral clefts
E M V M Silva, R H W Lacerda, I L Farias, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
December 26, 2021
Rectal cancer radiotherapy
V Vendrely, E Rivin Del Campo, A Modesto, et al.
Oral Oncology
|
June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
A Modesto, P Blanchard, Y G Tao, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry
|
April 4, 2013
Candidate gene studies in hypodontia suggest role for FGF3
A R Vieira, R N D'Souza, G Mues, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 10, 2024
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers]
F Guillemin, P Blanchard, P Boisselier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Y Tao, J Biau, X S Sun, et al.
Page
of 10